Table 4 The influence of medical specialist prescribing on the average number of days (SD) to the GP's first prescription for a new drug in the first six months after market introduction.
From: Is new drug prescribing in primary care specialist induced?
GPs starting therapy before repeating a specialist prescription | GPs starting therapy after repeating a specialist prescription | ||||
|---|---|---|---|---|---|
N | Mean days (SD) | N | Mean days (SD) | Pearson Chi-square | |
Salmeterol/fluticasone | 23 (67.6%) | 88.6 (36.3) | 11 (32.4%) | 109.0 (41.3) | 0.69 |
Rofecoxib | 28 (50.9%) | 71.7 (56.1) | 27 (49.1%) | 87.8 (42.5) | 0.56 |
Esomeprazole | 19 (70.4%) | 53.8 (43.8) | 8 (29.6%) | 87.3 (48.9) | 0.56 |
Tiotropium | 26 (40.0%) | 45.0 (46.5) | 39 (60.0%) | 88.0 (52.7) | 0.60 |
Rosuvastatin | 23 (67.6%) | 43.1 (40.1) | 11 (32.4%) | 108.8 (48.1) | 0.34 |